Cardiology Today

Deconstructed Cardiology

Stay current with cardiovascular medicine without the time commitment. Every morning, we deliver concise audio summaries of the latest original research from top cardiology journals. Top 5 breakthrough studies briefed in under 5 minutes (perfect for your commute or between patients). PubMed links included for full articles. Perfect for cardiologists, cardiothoracic surgeons, cardiac nurses, researchers, and healthcare workers who need to stay informed but lack time to scan multiple journals daily. For educational and reference purposes only. Not intended as medical advice.

  1. 1d ago

    Daratumumab for Pediatric Heart Transplant Rejection 08/08/26

    Welcome to Cardiology Today – Recorded August 08, 2026. This episode summarizes 5 key cardiology studies on topics like heart failure and endomyocardial biopsy. Key takeaway: Daratumumab for Pediatric Heart Transplant Rejection. Article Links: Article 1: Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study. (European heart journal) Article 2: Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies. (European heart journal) Article 3: Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating HLA Donor-Specific Antibody. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: Prognostic Significance of Myocardial Blood Flow Reserve and Stress Myocardial Blood Flow in the Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Impact of empagliflozin on serum calcium and phosphate in heart failure. (Journal of cardiac failure) Full episode page: https://podcast.explainheart.com/podcast/daratumumab-for-pediatric-heart-transplant-rejection-08-08-26/ Featured Articles Article 1: Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42568051 Summary: Endometriosis affects approximately 10 percent of women of reproductive age, with evidence linking it to systemic inflammation. This inflammatory process creates a recognized potential for increased venous thromboembolism risk. A Danish nationwide, registry-based cohort study comprehensively included all women with endometriosis from 1977 to 2024. The study rigorously matched these individuals 1 to 4 with controls based on birth and index year, representing a substantial effort to understand the association of endometriosis with long-term venous thromboembolism. Article 2: Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42568038 Summary: Heart failure management has seen significant therapeutic and interventional advances; however, real-world clinical practice remains poorly characterized. This investigation utilized two major Japanese heart failure registries: JROADHF from 2013, comprising 13238 patients, and JROADHF-NEXT from 2019 to 2021, comprising 4016 patients. Patient outcomes were rigorously compared between the cohorts using 1-to-1 propensity score matching. This extensive comparison provides a temporal evaluation of heart failure management and its impact on outcomes. Article 3: Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating HLA Donor-Specific Antibody. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42567380 Summary: L. A. Donor-Specific Antibody. Late graft survival following pediatric heart transplantation is inadequate, primarily due to chronic rejection. Daratumumab has demonstrated promise for treating antibody-mediated rejection, though published experience in heart transplantation is limited. This study retrospectively analyzed heart transplantation recipients who received daratumumab at a dose of 16 milligrams per kilogram for four doses. Treatment was administered for antibody-mediated rejection identified by elevated donor-derived cell-free D. N. A., without graft dysfunction or hemodynamic compromise, and confirmed by endomyocardial biopsy. Article 4: Prognostic Significance of Myocardial Blood Flow Reserve and Stress Myocardial Blood Flow in the Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42567379 Summary: Cardiac allograft vasculopathy significantly limits longevity following heart transplantation. Non-invasive physiological assessment using cardiac positron emission tomography offers established prognostic significance for this condition. This investigation included all adult single-organ heart transplant recipients who underwent Nitrogen-13 ammonia positron emission tomography myocardial perfusion imaging between 2016 and 2019. The study performed a median follow-up to measure the prognostic contribution of stress myocardial blood flow and myocardial blood flow reserve to post-transplant outcomes. Article 5: Impact of empagliflozin on serum calcium and phosphate in heart failure. Journal: Journal of cardiac failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42567257 Summary: Alterations in serum calcium and phosphate balance are associated with poor outcomes in heart failure, with existing data primarily from small observational studies. The effect of sodium-glucose cotransporter two inhibitors on serum calcium and phosphate levels has not been thoroughly examined in large, randomized heart failure trials. This study utilized comprehensive data from the EMPEROR-Pooled trials. The analysis focused on evaluating the prognostic associations of serum calcium and phosphate in heart failure patients and the specific impact of sodium-glucose cotransporter two inhibitors on these levels. Transcript Today’s date is August 08, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study. Endometriosis affects approximately 10 percent of women of reproductive age, with evidence linking it to systemic inflammation. This inflammatory process creates a recognized potential for increased venous thromboembolism risk. A Danish nationwide, registry-based cohort study comprehensively included all women with endometriosis from 1977 to 2024. The study rigorously matched these individuals 1 to 4 with controls based on birth and index year, representing a substantial effort to understand the association of endometriosis with long-term venous thromboembolism. Article number two. Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies. Heart failure management has seen significant therapeutic and interventional advances; however, real-world clinical practice remains poorly characterized. This investigation utilized two major Japanese heart failure registries: JROADHF from 2013, comprising 13238 patients, and JROADHF-NEXT from 2019 to 2021, comprising 4016 patients. Patient outcomes were rigorously compared between the cohorts using 1-to-1 propensity score matching. This extensive comparison provides a temporal evaluation of heart failure management and its impact on outcomes. Article number three. Daratumumab for Non-Acute Antibody-Mediated Rejection After Pediatric Heart Transplantation: Treatment Response in the Presence and Absence of Circulating H. L. A. Donor-Specific Antibody. Late graft survival following pediatric heart transplantation is inadequate, primarily due to chronic rejection. Daratumumab has demonstrated promise for treating antibody-mediated rejection, though published experience in heart transplantation is limited. This study retrospectively analyzed heart transplantation recipients who received daratumumab at a dose of 16 milligrams per kilogram for four doses. Treatment was administered for antibody-mediated rejection identified by elevated donor-derived cell-free D. N. A., without graft dysfunction or hemodynamic compromise, and confirmed by endomyocardial biopsy. Article number four. Prognostic Significance of Myocardial Blood Flow Reserve and Stress Myocardial Blood Flow in the Assessment of Cardiac Allograft Vasculopathy in Heart Transplant Recipients. Cardiac allograft vasculopathy significantly limits longevity following heart transplantation. Non-invasive physiological assessment using cardiac positron emission tomography offers established prognostic significance for this condition. This investigation included all adult single-organ heart transplant recipients who underwent Nitrogen-13 ammonia positron emission tomography myocardial perfusion imaging between 2016 and 2019. The study performed a median follow-up to measure the prognostic contribution of stress myocardial blood flow and myocardial blood flow reserve to post-transplant outcomes. Article number five. Impact of empagliflozin on serum calcium and phosphate in heart failure. Alterations in serum calcium and phosphate balance are associated with poor outcomes in heart failure, with existing data primarily from small observational studies. The effect of sodium-glucose cotransporter two inhibitors on serum calcium and phosphate levels has not been thoroughly examined in large, randomized heart failure trials. This study utilized comprehensive data from the EMPEROR-Pooled trials. The analysis focused on evaluating the prognostic associations of serum calcium and phosphate in heart failure patients and the specific impact of sodium-glucose cotransporter two inhibitors on these levels. Thank you for listening. Don’t forget to subscribe. Keywords heart failure, endomyocardial biopsy, cohort study, sodium-glucose cotransporter two inhibitors, daratumumab, stress myocardial blood flow, empagliflozin, pediatric heart transplantation, clinical practice, antibody-mediated rejection, endometriosis, venous thromboembolism, positron emission tomography, serum cal

  2. 2d ago

    Xenotransplant Progress: Pigs Mitigate Rejection 08/07/26

    Welcome to Cardiology Today – Recorded August 07, 2026. This episode summarizes 5 key cardiology studies on topics like tricuspid regurgitation and pathogen detection. Key takeaway: Xenotransplant Progress: Pigs Mitigate Rejection. Article Links: Article 1: Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation: a propensity-matched analysis. (European heart journal) Article 2: Senescence-associated metabolic alterations aggravate calcific aortic valve disease. (European heart journal) Article 3: Risk factors and coronary events: attenuation of the association in secondary prevention. (European heart journal) Article 4: Improved Sensitivity for Respiratory Pathogen Detection in Bronchoalveolar Lavage from Lung Transplant Recipients Using Targeted Next-Generation Sequencing. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: From Gene Editing to Exogenesis: Pigs as a Source of Immune-compatible Organs for Transplantation. (Transplantation) Full episode page: https://podcast.explainheart.com/podcast/xenotransplant-progress-pigs-mitigate-rejection-08-07-26/ Featured Articles Article 1: Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation: a propensity-matched analysis. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42030119 Summary: Transcatheter edge-to-edge repair represents a therapeutic strategy for the complex coexistence of moderate mitral regurgitation, or M. R., and severe tricuspid regurgitation, or T. R. Clinically, the management choice involves either combined mitral and tricuspid valve repair or isolated tricuspid valve repair. The study established the prognostic relevance of moderate M. R. in patients undergoing tricuspid edge-to-edge repair for severe T. R. It also delineated the potential benefits and comparative effectiveness of adding concomitant mitral edge-to-edge repair, highlighting a crucial aspect of dual valve disease management. Article 2: Senescence-associated metabolic alterations aggravate calcific aortic valve disease. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41841768 Summary: Calcific aortic valve disease, or C. A. V. D., a condition without effective drug treatments, is fundamentally linked to the aging process. The progressive decline of nicotinamide adenine dinucleotide, or N. A. D. plus, with age plays a critical role in this disease pathology. This research identified that specific disruptions in N. A. D. plus salvage metabolism within certain cell types contribute to valvular inflammation and calcification. The study provided detailed mapping of N. A. D. plus pathways using integrated human aortic valve ribonucleic acid sequencing and single-cell transcriptomics, showing effects related to nicotinamide phosphoribosyltransferase. Article 3: Risk factors and coronary events: attenuation of the association in secondary prevention. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42556799 Summary: For individuals who have survived coronary heart disease, or C. H. D., the association between traditional risk factors and subsequent cardiovascular events often appears diminished or even contradictory. This phenomenon complicates accurate clinical interpretation and risk prediction in secondary prevention settings. The study demonstrated that this observation represents a systemic characteristic of studying disease survivors rather than unique to specific risk factors requiring biological explanations. Researchers analyzed a large retrospective longitudinal cohort of over 3275000 adults initially free of cardiovascular disease, or C. V. D., confirming these attenuated risk factor associations in secondary prevention. Article 4: Improved Sensitivity for Respiratory Pathogen Detection in Bronchoalveolar Lavage from Lung Transplant Recipients Using Targeted Next-Generation Sequencing. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42551813 Summary: Next-generation sequencing, or N. G. S., offers improved pathogen detection for pulmonary infections among lung transplant recipients, or L. T. R.s. This diagnostic approach was systematically compared against conventional cultures in parallel bronchoalveolar lavage, or B. A. L., specimens. The study assessed the positivity rates, sensitivity, and specificity of N. G. S. relative to a composite reference for infection. It also evaluated N. G. S. species-level diagnostic accuracy against culture results, providing crucial comparative data from 122 bronchoscopies across 31 L. T. R.s. Article 5: From Gene Editing to Exogenesis: Pigs as a Source of Immune-compatible Organs for Transplantation. Journal: Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42547936 Summary: Persistent shortages of human organs have driven the development of alternative sources, particularly xenotransplantation using genetically engineered pigs. Significant progress has been made in creating multigene-modified pigs that lack glycan xenoantigens. These pigs also express human complement and coagulation regulators, enhancing compatibility. These genetic modifications have successfully mitigated hyperacute and delayed xenograft rejection, marking a critical advancement in making pig organs immune-compatible for human transplantation. Transcript Today’s date is August 07, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation: a propensity-matched analysis. Transcatheter edge-to-edge repair represents a therapeutic strategy for the complex coexistence of moderate mitral regurgitation, or M. R., and severe tricuspid regurgitation, or T. R. Clinically, the management choice involves either combined mitral and tricuspid valve repair or isolated tricuspid valve repair. The study established the prognostic relevance of moderate M. R. in patients undergoing tricuspid edge-to-edge repair for severe T. R. It also delineated the potential benefits and comparative effectiveness of adding concomitant mitral edge-to-edge repair, highlighting a crucial aspect of dual valve disease management. Article number two. Senescence-associated metabolic alterations aggravate calcific aortic valve disease. Calcific aortic valve disease, or C. A. V. D., a condition without effective drug treatments, is fundamentally linked to the aging process. The progressive decline of nicotinamide adenine dinucleotide, or N. A. D. plus, with age plays a critical role in this disease pathology. This research identified that specific disruptions in N. A. D. plus salvage metabolism within certain cell types contribute to valvular inflammation and calcification. The study provided detailed mapping of N. A. D. plus pathways using integrated human aortic valve ribonucleic acid sequencing and single-cell transcriptomics, showing effects related to nicotinamide phosphoribosyltransferase. Article number three. Risk factors and coronary events: attenuation of the association in secondary prevention. For individuals who have survived coronary heart disease, or C. H. D., the association between traditional risk factors and subsequent cardiovascular events often appears diminished or even contradictory. This phenomenon complicates accurate clinical interpretation and risk prediction in secondary prevention settings. The study demonstrated that this observation represents a systemic characteristic of studying disease survivors rather than unique to specific risk factors requiring biological explanations. Researchers analyzed a large retrospective longitudinal cohort of over 3275000 adults initially free of cardiovascular disease, or C. V. D., confirming these attenuated risk factor associations in secondary prevention. Article number four. Improved Sensitivity for Respiratory Pathogen Detection in Bronchoalveolar Lavage from Lung Transplant Recipients Using Targeted Next-Generation Sequencing. Next-generation sequencing, or N. G. S., offers improved pathogen detection for pulmonary infections among lung transplant recipients, or L. T. R.s. This diagnostic approach was systematically compared against conventional cultures in parallel bronchoalveolar lavage, or B. A. L., specimens. The study assessed the positivity rates, sensitivity, and specificity of N. G. S. relative to a composite reference for infection. It also evaluated N. G. S. species-level diagnostic accuracy against culture results, providing crucial comparative data from 122 bronchoscopies across 31 L. T. R.s. Article number five. From Gene Editing to Exogenesis: Pigs as a Source of Immune-compatible Organs for Transplantation. Persistent shortages of human organs have driven the development of alternative sources, particularly xenotransplantation using genetically engineered pigs. Significant progress has been made in creating multigene-modified pigs that lack glycan xenoantigens. These pigs also express human complement and coagulation regulators, enhancing compatibility. These genetic modifications have successfully mitigated hyperacute and delayed xenograft rejection, marking a critical advancement in making pig organs immune-compatible for human transplantation. Thank you for listening. Don’t forget to subscribe. Keywords tricuspid regurgitation, pathogen detection, secondary prevention, genetic modifications, xenotransplantation, lung transplant recipients, aging, risk factors, mitral regurgitation, calcific aortic valve disease, next-generation sequenci

  3. 3d ago

    Finerenone Improves Cardio-Renal Outcomes 08/06/26

    Welcome to Cardiology Today – Recorded August 06, 2026. This episode summarizes 5 key cardiology studies on topics like diabetes and cardiometabolic risk factors. Key takeaway: Finerenone Improves Cardio-Renal Outcomes. Article Links: Article 1: Conservative Oxygen for Unresponsive Patients after Cardiac Arrest. (The New England journal of medicine) Article 2: Finerenone in Persons with Chronic Kidney Disease without Diabetes. (The New England journal of medicine) Article 3: Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome. (Journal of the American College of Cardiology) Article 4: Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis. (Journal of the American College of Cardiology) Article 5: Periodontitis, epicardial adipose tissue and coronary events: the Swedish Cardiopulmonary Bioimage Study. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/finerenone-improves-cardio-renal-outcomes-08-06-26/ Featured Articles Article 1: Conservative Oxygen for Unresponsive Patients after Cardiac Arrest. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42267831 Summary: This study randomized unresponsive adults receiving mechanical ventilation in the intensive care unit after cardiac arrest to either conservative or liberal oxygen therapy. It compared the clinical impact of distinct arterial oxygen saturation targets following resuscitation. The research specifically evaluated whether limiting oxygen exposure, as opposed to a more liberal approach, affects the likelihood of survival with a favorable functional outcome. This investigation clarifies optimal oxygen management strategies for post-cardiac arrest care. Article 2: Finerenone in Persons with Chronic Kidney Disease without Diabetes. Journal: The New England journal of medicine PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42246672 Summary: Previous randomized trials showed that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type two diabetes and chronic kidney disease. This study randomized adults without diabetes who had chronic kidney disease and albuminuria. Participants had an estimated glomerular filtration rate between 25 and less than 90 milliliters per minute per 1.73 square meters of body-surface area. The research evaluated finerenone’s effects on kidney and cardiovascular outcomes in this specific non-diabetic patient population. Article 3: Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42307495 Summary: Adults With Cardiovascular-Kidney-Metabolic Syndrome. This study characterized national treatment rates of major cardiometabolic risk factors among U.S. adults with cardiovascular-kidney-metabolic syndrome. It identified contemporary treatment patterns for hypertension and diabetes in this high-risk population. The research clarified intervention targets within the interconnected cardiometabolic, kidney, and cardiovascular disease landscape. This characterization provides a foundation for defining optimal intervention strategies amid rising cardiovascular mortality. Article 4: Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis. Journal: Journal of the American College of Cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42233928 Summary: Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated improved cardiovascular and kidney outcomes in patients with cardiovascular-kidney-metabolic syndrome. The FINE-HEART analysis specifically investigated the effects of finerenone on sudden death within this patient population. This prespecified analysis pooled participant-level data from three placebo-controlled trials of finerenone. It meticulously examined independent predictors of sudden death and finerenone’s impact on this outcome. Article 5: Periodontitis, epicardial adipose tissue and coronary events: the Swedish Cardiopulmonary Bioimage Study. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42555521 Summary: This study investigated the mechanistic role of subclinical atherosclerosis in the relationship between periodontitis and coronary heart disease. Researchers examined whether subclinical atherosclerosis mediates the association between periodontitis and incident coronary heart disease. The study also evaluated how a specific periodontitis phenotype modifies subclinical coronary atherosclerosis and its association with epicardial adipose tissue attenuation, a marker of inflammation. This research clarifies the complex interplay between oral health and cardiovascular disease mechanisms. Transcript Today’s date is August 06, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Conservative Oxygen for Unresponsive Patients after Cardiac Arrest. This study randomized unresponsive adults receiving mechanical ventilation in the intensive care unit after cardiac arrest to either conservative or liberal oxygen therapy. It compared the clinical impact of distinct arterial oxygen saturation targets following resuscitation. The research specifically evaluated whether limiting oxygen exposure, as opposed to a more liberal approach, affects the likelihood of survival with a favorable functional outcome. This investigation clarifies optimal oxygen management strategies for post-cardiac arrest care. Article number two. Finerenone in Persons with Chronic Kidney Disease without Diabetes. Previous randomized trials showed that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type two diabetes and chronic kidney disease. This study randomized adults without diabetes who had chronic kidney disease and albuminuria. Participants had an estimated glomerular filtration rate between 25 and less than 90 milliliters per minute per 1.73 square meters of body-surface area. The research evaluated finerenone’s effects on kidney and cardiovascular outcomes in this specific non-diabetic patient population. Article number three. Treatment of Cardiometabolic Risk Factors Among U.S. Adults With Cardiovascular-Kidney-Metabolic Syndrome. This study characterized national treatment rates of major cardiometabolic risk factors among U.S. adults with cardiovascular-kidney-metabolic syndrome. It identified contemporary treatment patterns for hypertension and diabetes in this high-risk population. The research clarified intervention targets within the interconnected cardiometabolic, kidney, and cardiovascular disease landscape. This characterization provides a foundation for defining optimal intervention strategies amid rising cardiovascular mortality. Article number four. Effects of Finerenone on Sudden Death Across the Cardio-Kidney-Metabolic Landscape: A FINE-HEART Analysis. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated improved cardiovascular and kidney outcomes in patients with cardiovascular-kidney-metabolic syndrome. The FINE-HEART analysis specifically investigated the effects of finerenone on sudden death within this patient population. This prespecified analysis pooled participant-level data from three placebo-controlled trials of finerenone. It meticulously examined independent predictors of sudden death and finerenone’s impact on this outcome. Article number five. Periodontitis, epicardial adipose tissue and coronary events: the Swedish Cardiopulmonary Bioimage Study. This study investigated the mechanistic role of subclinical atherosclerosis in the relationship between periodontitis and coronary heart disease. Researchers examined whether subclinical atherosclerosis mediates the association between periodontitis and incident coronary heart disease. The study also evaluated how a specific periodontitis phenotype modifies subclinical coronary atherosclerosis and its association with epicardial adipose tissue attenuation, a marker of inflammation. This research clarifies the complex interplay between oral health and cardiovascular disease mechanisms. Thank you for listening. Don’t forget to subscribe. Keywords diabetes, cardiometabolic risk factors, albuminuria, sudden death, intensive care unit, coronary heart disease, cardiovascular-kidney-metabolic syndrome, resuscitation, periodontitis, mineralocorticoid receptor antagonist, cardiac arrest, mechanical ventilation, finerenone, cardiovascular outcomes, oxygen therapy, nonsteroidal mineralocorticoid receptor antagonist, chronic kidney disease, hypertension, subclinical atherosclerosis, inflammation, epicardial adipose tissue, treatment patterns, estimated glomerular filtration rate. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • Follow The post Finerenone Improves Cardio-Renal Outcomes 08/06/26 first appeared on Cardiology Today.

  4. 4d ago

    LMOD1 Loss Triggers Rapid Atherosclerosis. 08/05/26

    Welcome to Cardiology Today – Recorded August 05, 2026. This episode summarizes 5 key cardiology studies on topics like gene knockout and genetic predictors. Key takeaway: LMOD1 Loss Triggers Rapid Atherosclerosis.. Article Links: Article 1: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. (Circulation) Article 2: Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. (Circulation) Article 3: COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. (Circulation) Article 4: Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis. (Circulation) Article 5: Side effects in hypertension treatment: a pharmacogenomic analysis. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/lmod1-loss-triggers-rapid-atherosclerosis-08-05-26/ Featured Articles Article 1: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549517 Summary: This COMBINE-AF analysis identified extracranial bleeding as the most common complication of oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation. Researchers characterized these bleeding events according to standardized severity definitions. The study identified baseline risk factors for bleeding and quantified their population attributable fraction in patients receiving oral anticoagulants. Article 2: Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549514 Summary: This study found that the protein LAPTM4A facilitates autophagosome-lysosome fusion. This specific mechanism attenuates myocardial ischemia-reperfusion injury, which otherwise leads to functional impairment and structural damage in the heart. The findings demonstrate LAPTM4A as a novel strategy to limit damage caused by myocardial ischemia-reperfusion injury, addressing a critical unmet clinical need. Article 3: COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549511 Summary: This research demonstrated that the interaction between COL1A1 and CD44/SLC7A11 enhances cystine uptake. This specific process results in the accumulation of CD34 positive foam-like macrophages in transplant arteriosclerosis. These findings elucidate key regulatory mechanisms of macrophages in allograft arteriosclerosis, offering a foundation for developing targeted therapies against chronic transplant arteriosclerosis, a primary cause of long-term graft failure. Article 4: Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42549503 Summary: This study found that the loss of the Coronary Artery Disease risk gene LMOD1 specifically in vascular smooth muscle cells triggers rapid-onset coronary atherosclerosis. The results establish LMOD1 as a critical regulator in vascular smooth muscle cell function. This finding reveals a previously unknown role for LMOD1 in coronary artery pathophysiology and the development of atherosclerosis. Article 5: Side effects in hypertension treatment: a pharmacogenomic analysis. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42545033 Summary: This extensive pharmacogenomic analysis classified short-term antihypertensive medication use trajectories from over 400000 genotyped users across three cohorts. The study addressed the challenge that up to half of patients switch or discontinue antihypertensive medications within the first year due to elusive underlying mechanisms. This large-scale analysis provided a framework for investigating genetic influences on these medication patterns. Transcript Today’s date is August 05, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis. This COMBINE-AF analysis identified extracranial bleeding as the most common complication of oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation. Researchers characterized these bleeding events according to standardized severity definitions. The study identified baseline risk factors for bleeding and quantified their population attributable fraction in patients receiving oral anticoagulants. Article number two. Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury. This study found that the protein LAPTM4A facilitates autophagosome-lysosome fusion. This specific mechanism attenuates myocardial ischemia-reperfusion injury, which otherwise leads to functional impairment and structural damage in the heart. The findings demonstrate LAPTM4A as a novel strategy to limit damage caused by myocardial ischemia-reperfusion injury, addressing a critical unmet clinical need. Article number three. COL1A1-Enhanced CD44/SLC7A11 Interaction and Cystine Uptake Result in CD34+ Foam-Like Macrophage Accumulation in Transplant Arteriosclerosis. This research demonstrated that the interaction between COL1A1 and CD44/SLC7A11 enhances cystine uptake. This specific process results in the accumulation of CD34 positive foam-like macrophages in transplant arteriosclerosis. These findings elucidate key regulatory mechanisms of macrophages in allograft arteriosclerosis, offering a foundation for developing targeted therapies against chronic transplant arteriosclerosis, a primary cause of long-term graft failure. Article number four. Loss of the Coronary Artery Disease Risk Gene LMOD1 in Vascular Smooth Muscle Cells Triggers Rapid-Onset Coronary Atherosclerosis. This study found that the loss of the Coronary Artery Disease risk gene LMOD1 specifically in vascular smooth muscle cells triggers rapid-onset coronary atherosclerosis. The results establish LMOD1 as a critical regulator in vascular smooth muscle cell function. This finding reveals a previously unknown role for LMOD1 in coronary artery pathophysiology and the development of atherosclerosis. Article number five. Side effects in hypertension treatment: a pharmacogenomic analysis. This extensive pharmacogenomic analysis classified short-term antihypertensive medication use trajectories from over 400000 genotyped users across three cohorts. The study addressed the challenge that up to half of patients switch or discontinue antihypertensive medications within the first year due to elusive underlying mechanisms. This large-scale analysis provided a framework for investigating genetic influences on these medication patterns. Thank you for listening. Don’t forget to subscribe. Keywords gene knockout, genetic predictors, graft failure, therapeutic strategy, bleeding risk factors, LAPTM4A, extracranial bleeding, LMOD1, CD34 positive macrophages, macrophage accumulation, vascular smooth muscle cells, cardiac damage, COL1A1, stroke prevention, myocardial ischemia-reperfusion injury, pharmacogenomics, hypertension, oral anticoagulants, atherosclerosis, autophagosome-lysosome fusion, antihypertensive medications, medication adherence, transplant arteriosclerosis, atrial fibrillation, coronary artery disease. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • Follow The post LMOD1 Loss Triggers Rapid Atherosclerosis. 08/05/26 first appeared on Cardiology Today.

  5. 5d ago

    Mitochondrial Damage Drives Heart Failure 08/04/26

    Welcome to Cardiology Today – Recorded August 04, 2026. This episode summarizes 5 key cardiology studies on topics like cardiac contraction and markers of ultra-processing. Key takeaway: Mitochondrial Damage Drives Heart Failure. Article Links: Article 1: Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy. (Circulation) Article 2: Association of Pulmonary Vascular Remodeling With Cardiac Structure and Function, Pulmonary Pressure, and Heart Failure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study. (Circulation) Article 3: Loss of STMP1 Perturbs Mitochondrial Cristae and Drives Cellular Inflammation and Heart Failure. (Circulation) Article 4: SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure. (Circulation) Article 5: Markers of ultra-processed food and incident arterial hypertension in the UK Biobank. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/mitochondrial-damage-drives-heart-failure-08-04-26/ Featured Articles Article 1: Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42546101 Summary: Left ventricular hypertrabeculation, previously known as left ventricular noncompaction, represents a heterogeneous myocardial condition. This study found that the presence of hypertrabeculation in patients with dilated cardiomyopathy (D. C. M.) correlated with an altered embolic risk profile. The research determined its prevalence and established its prognostic relevance across various dilated cardiomyopathy genotypes. These findings provide crucial information for understanding patient stratification and risk assessment in dilated cardiomyopathy. Article 2: Association of Pulmonary Vascular Remodeling With Cardiac Structure and Function, Pulmonary Pressure, and Heart Failure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42478373 Summary: This study found a significant association between pulmonary vascular arterial remodeling, characterized by distal pruning and proximal dilation, and various cardiac parameters. Specifically, it demonstrated correlations with cardiac structure and function, including age-associated left ventricular remodeling and diastolic dysfunction. The research established links between these pulmonary arterial changes and elevated pulmonary pressure, as well as the incidence of heart failure in late life. These findings highlight the interplay between pulmonary vascular health and cardiac function in an aging population. Article 3: Loss of STMP1 Perturbs Mitochondrial Cristae and Drives Cellular Inflammation and Heart Failure. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42267405 Summary: This study found that the loss of STMP1 significantly perturbs mitochondrial cristae integrity within cells. Compromised mitochondrial cristae led to a cytoplasmic leak of mitochondrial D. N. A., which in turn triggered persistent low-grade cellular inflammation. This inflammatory response occurred through the activation of the cGAS (cyclic G. M. P. A. M. P. synthase)-STING (stimulator of interferon genes) pathway and subsequently type one interferon. The research concluded that this mechanistic pathway driven by STMP1 loss actively drives cellular inflammation and contributes to the progression of heart failure. Article 4: SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure. Journal: Circulation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42170742 Summary: This study found that sterol regulatory element-binding protein one (S. R. E. B. P. one) transactivation of sodium hydrogen exchanger three (N. H. E. three) directly impairs cardiac contraction. The research demonstrated that this pathway contributes to the dysregulation of intracellular ion cycling, specifically sodium and hydrogen, which is fundamental to reduced cardiac contractility. The findings revealed a critical mechanism linking myocardial stress to these ion imbalances. Ultimately, the study concluded that S. R. E. B. P. one transactivation of N. H. E. three aggravates heart failure, particularly heart failure with reduced ejection fraction (H. F. r. E. F.). Article 5: Markers of ultra-processed food and incident arterial hypertension in the UK Biobank. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42545878 Summary: This prospective cohort study, involving 101560 non-hypertensive U. K. Biobank participants, found a positive association between the intake of ultra-processed food (U. P. F.) and incident arterial hypertension. The research specifically assessed and identified associations with particular markers of ultra-processing (M. U. P. s) that had not been previously evaluated. Participants’ dietary intake was captured via 24-hour dietary recalls, and ultra-processed foods were identified by matching commercial products to food items. The data demonstrated that specific markers within ultra-processed foods independently correlated with the development of new-onset hypertension. Transcript Today’s date is August 04, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy. Left ventricular hypertrabeculation, previously known as left ventricular noncompaction, represents a heterogeneous myocardial condition. This study found that the presence of hypertrabeculation in patients with dilated cardiomyopathy (D. C. M.) correlated with an altered embolic risk profile. The research determined its prevalence and established its prognostic relevance across various dilated cardiomyopathy genotypes. These findings provide crucial information for understanding patient stratification and risk assessment in dilated cardiomyopathy. Article number two. Association of Pulmonary Vascular Remodeling With Cardiac Structure and Function, Pulmonary Pressure, and Heart Failure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study. This study found a significant association between pulmonary vascular arterial remodeling, characterized by distal pruning and proximal dilation, and various cardiac parameters. Specifically, it demonstrated correlations with cardiac structure and function, including age-associated left ventricular remodeling and diastolic dysfunction. The research established links between these pulmonary arterial changes and elevated pulmonary pressure, as well as the incidence of heart failure in late life. These findings highlight the interplay between pulmonary vascular health and cardiac function in an aging population. Article number three. Loss of STMP1 Perturbs Mitochondrial Cristae and Drives Cellular Inflammation and Heart Failure. This study found that the loss of STMP1 significantly perturbs mitochondrial cristae integrity within cells. Compromised mitochondrial cristae led to a cytoplasmic leak of mitochondrial D. N. A., which in turn triggered persistent low-grade cellular inflammation. This inflammatory response occurred through the activation of the cGAS (cyclic G. M. P. A. M. P. synthase)-STING (stimulator of interferon genes) pathway and subsequently type one interferon. The research concluded that this mechanistic pathway driven by STMP1 loss actively drives cellular inflammation and contributes to the progression of heart failure. Article number four. SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure. This study found that sterol regulatory element-binding protein one (S. R. E. B. P. one) transactivation of sodium hydrogen exchanger three (N. H. E. three) directly impairs cardiac contraction. The research demonstrated that this pathway contributes to the dysregulation of intracellular ion cycling, specifically sodium and hydrogen, which is fundamental to reduced cardiac contractility. The findings revealed a critical mechanism linking myocardial stress to these ion imbalances. Ultimately, the study concluded that S. R. E. B. P. one transactivation of N. H. E. three aggravates heart failure, particularly heart failure with reduced ejection fraction (H. F. r. E. F.). Article number five. Markers of ultra-processed food and incident arterial hypertension in the UK Biobank. This prospective cohort study, involving 101560 non-hypertensive U. K. Biobank participants, found a positive association between the intake of ultra-processed food (U. P. F.) and incident arterial hypertension. The research specifically assessed and identified associations with particular markers of ultra-processing (M. U. P. s) that had not been previously evaluated. Participants’ dietary intake was captured via 24-hour dietary recalls, and ultra-processed foods were identified by matching commercial products to food items. The data demonstrated that specific markers within ultra-processed foods independently correlated with the development of new-onset hypertension. Thank you for listening. Don’t forget to subscribe. Keywords cardiac contraction, markers of ultra-processing, aging, ultra-processed food, SREBP1, heart failure, embolic risk, ion cycling, U. K. Biobank, NHE3, heart failure with reduced ejection fraction, pulmonary vascular remodeling, pulmonary pressure, genetic testing, cellular inflammation, dietary recall, cGAS-STING pathway, dilated cardiomyopathy, mitochondrial cristae, STMP1, arterial hypertension, prognosis, left ventricular hypertrabeculation, cardiac structure. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • Follow The post Mitochondrial Damage Drives Heart Failure 08/04/26 first appeared on Cardiology Today.

  6. 6d ago

    Adult Congenital Heart Disease: New Complications 08/03/26

    Welcome to Cardiology Today – Recorded August 03, 2026. This episode summarizes 5 key cardiology studies on topics like ventricular tachycardia and prevalence. Key takeaway: Adult Congenital Heart Disease: New Complications. Article Links: Article 1: Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement. (European heart journal) Article 2: Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease. (European heart journal) Article 3: Subvalvular aortic stenosis in adults: clinical course and long-term outcomes. (European heart journal) Article 4: Heart failure with preserved ejection fraction in adults with congenital heart disease. (European heart journal) Article 5: Congenital heart defects: familial recurrence patterns in Sweden. (European heart journal) Full episode page: https://podcast.explainheart.com/podcast/adult-congenital-heart-disease-new-complications-08-03-26/ Featured Articles Article 1: Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42206474 Summary: Adults with repaired Tetralogy of Fallot face significant long-term risks of ventricular tachycardia and sudden cardiac death. This study described the clinical strategy of pre-operative electrophysiological testing to guide intraoperative cryoablation during pulmonary valve replacement. This therapeutic approach targeted identified anatomical arrhythmia substrates. The investigation focused on its association with reduced post-operative ventricular tachycardia inducibility and the long-term risk of clinical ventricular tachycardia and sudden cardiac death. Article 2: Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42112702 Summary: Adults with congenital heart disease have improved life expectancy, leading to an increased focus on age-related comorbidities like acute myocardial infarction. This nationwide case-control study compared outcomes following a first acute myocardial infarction in patients with and without congenital heart disease. Researchers included 214 adults with congenital heart disease and 275377 controls without, evaluating all-cause mortality and recurrent acute myocardial infarction. This investigation provides crucial data on the clinical course of acute myocardial infarction within the adult congenital heart disease population. Article 3: Subvalvular aortic stenosis in adults: clinical course and long-term outcomes. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41635281 Summary: This study characterized the clinical course and long-term outcomes in adults diagnosed with subvalvular aortic stenosis. It included patients from the Dutch Congenital Cor Vitia registry, following them between 2001 and 2019. The investigation assessed all-cause mortality, rates of subvalvular aortic stenosis re-operation, and cardiovascular events. Key cardiovascular events included arrhythmias, heart failure, and re-operations for aortic regurgitation. Article 4: Heart failure with preserved ejection fraction in adults with congenital heart disease. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41614664 Summary: Heart failure with preserved ejection fraction is a growing concern in the general population, but its prevalence among adults with congenital heart disease remains largely unknown. This multicenter cohort study described the prevalence, characteristics, and hospitalization burden of heart failure with preserved ejection fraction within this specific patient group. Researchers analyzed electronic medical files of 4507 adults with congenital heart disease who had biventricular heart physiology and systemic left ventricles. The study provided foundational data on heart failure with preserved ejection fraction in adult congenital heart disease. Article 5: Congenital heart defects: familial recurrence patterns in Sweden. Journal: European heart journal PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41504464 Summary: Congenital heart defects are known to aggregate within families, yet their recurrence patterns across different kinship types and generations are not fully understood. This nationwide, population-based case-control study in Sweden investigated these familial recurrence patterns among relatives. Researchers included 51778 individuals diagnosed with congenital heart defects who were born between 1987 and 2017. The study provided updated population-based estimates essential for genetic counseling and risk stratification. Transcript Today’s date is August 03, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement. Adults with repaired Tetralogy of Fallot face significant long-term risks of ventricular tachycardia and sudden cardiac death. This study described the clinical strategy of pre-operative electrophysiological testing to guide intraoperative cryoablation during pulmonary valve replacement. This therapeutic approach targeted identified anatomical arrhythmia substrates. The investigation focused on its association with reduced post-operative ventricular tachycardia inducibility and the long-term risk of clinical ventricular tachycardia and sudden cardiac death. Article number two. Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease. Adults with congenital heart disease have improved life expectancy, leading to an increased focus on age-related comorbidities like acute myocardial infarction. This nationwide case-control study compared outcomes following a first acute myocardial infarction in patients with and without congenital heart disease. Researchers included 214 adults with congenital heart disease and 275377 controls without, evaluating all-cause mortality and recurrent acute myocardial infarction. This investigation provides crucial data on the clinical course of acute myocardial infarction within the adult congenital heart disease population. Article number three. Subvalvular aortic stenosis in adults: clinical course and long-term outcomes. This study characterized the clinical course and long-term outcomes in adults diagnosed with subvalvular aortic stenosis. It included patients from the Dutch Congenital Cor Vitia registry, following them between 2001 and 2019. The investigation assessed all-cause mortality, rates of subvalvular aortic stenosis re-operation, and cardiovascular events. Key cardiovascular events included arrhythmias, heart failure, and re-operations for aortic regurgitation. Article number four. Heart failure with preserved ejection fraction in adults with congenital heart disease. Heart failure with preserved ejection fraction is a growing concern in the general population, but its prevalence among adults with congenital heart disease remains largely unknown. This multicenter cohort study described the prevalence, characteristics, and hospitalization burden of heart failure with preserved ejection fraction within this specific patient group. Researchers analyzed electronic medical files of 4507 adults with congenital heart disease who had biventricular heart physiology and systemic left ventricles. The study provided foundational data on heart failure with preserved ejection fraction in adult congenital heart disease. Article number five. Congenital heart defects: familial recurrence patterns in Sweden. Congenital heart defects are known to aggregate within families, yet their recurrence patterns across different kinship types and generations are not fully understood. This nationwide, population-based case-control study in Sweden investigated these familial recurrence patterns among relatives. Researchers included 51778 individuals diagnosed with congenital heart defects who were born between 1987 and 2017. The study provided updated population-based estimates essential for genetic counseling and risk stratification. Thank you for listening. Don’t forget to subscribe. Keywords ventricular tachycardia, prevalence, pulmonary valve replacement, Tetralogy of Fallot, long-term outcomes, congenital heart disease, aortic regurgitation, Heart Failure with Preserved Ejection Fraction, congenital heart defects, genetic counseling, all-cause mortality, population-based study, familial recurrence, hospitalization burden, acute myocardial infarction, subvalvular aortic stenosis, adult congenital heart disease, electrophysiology-guided ablation. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • Follow The post Adult Congenital Heart Disease: New Complications 08/03/26 first appeared on Cardiology Today.

  7. Aug 2

    Donor Heart Biology: Cardiac vs Brain Death 08/02/26

    Welcome to Cardiology Today – Recorded August 02, 2026. This episode summarizes 5 key cardiology studies on topics like respiratory support and registry analysis. Key takeaway: Donor Heart Biology: Cardiac vs Brain Death. Article Links: Article 1: Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 2: Determining an optimal central cannulation strategy for ambulatory veno-venous extracorporeal life support. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 3: Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 4: The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Full episode page: https://podcast.explainheart.com/podcast/donor-heart-biology-cardiac-vs-brain-death-08-02-26/ Featured Articles Article 1: Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41951134 Summary: A retrospective analysis utilizing the Cardiogenic Shock Working Group registry provided comparative data on patient trajectories and outcomes in cardiogenic shock. The study specifically compared individuals receiving heart replacement therapies versus those who did not during their index hospitalization. Cardiogenic shock severity was characterized using Society for Cardiovascular Angiography and Interventions stages, machine learning-derived phenotypes, and the Comorbidity Risk Index. This analysis yielded foundational comparative insights into patient courses under different management strategies for severe cardiogenic shock. Article 2: Determining an optimal central cannulation strategy for ambulatory veno-venous extracorporeal life support. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41949527 Summary: To address suboptimal cannulation for durable veno-venous extracorporeal membrane oxygenation support in end-stage chronic obstructive pulmonary disease, four novel central cannulation strategies were designed, fabricated, and evaluated. Current configurations for long-term respiratory support are suboptimal, prompting the development of these new approaches for durable artificial lung therapies. The evaluation provided crucial insights into improved cannulation configurations, offering critical alternatives for chronic obstructive pulmonary disease patients facing donor lung scarcity. This work advances long-term physiological support for patients requiring prolonged respiratory assistance. Article 3: Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41949525 Summary: This study investigated single-beat right ventricular-pulmonary artery coupling using elastance-based indices to identify residual heart failure risk in 70 adults with HeartMate 3 left ventricular assist devices. Patients underwent pre-discharge right heart catheterization after optimized device support. The findings demonstrated how right ventricular-pulmonary artery interaction, measured via specific indices, correlates with the presence of ongoing heart failure despite left ventricular assist device implantation. This work provides new understanding of the mechanisms contributing to residual heart failure in this population. Article 4: The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41935548 Summary: The A. S. S. I. S. T. chronic lung allograft dysfunction study, a multicenter, phase two, double-blind, randomized controlled trial, demonstrated the impact of intravenous allogenic bone marrow-derived mesenchymal stromal cells in lung transplant recipients with new-onset chronic lung allograft dysfunction. This trial, involving participants aged 18 years or older more than six months post-transplant, focused on those with a persistent fall in forced expiratory volume in one second. The findings established the safety and initial efficacy profile of mesenchymal stromal cells as a therapeutic strategy for this primary limitation to long-term survival after lung transplantation. This work provides evidence for the use of mesenchymal stromal cells in mitigating chronic lung allograft dysfunction. Article 5: Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41881141 Summary: This study performed single-nuclei ribonucleic acid sequencing and metabolomics on the human left ventricle, revealing fundamentally different cardiac biology between hearts donated after brain death versus cardiac death. The data demonstrated that hearts donated after cardiac death are specifically marked by ischemic metabolic responses and the generation of oxidative substances. These findings provide critical molecular insights into the distinct physiological states of donor hearts, which can inform preservation strategies. This differential transcriptomic and metabolomic landscape highlights the need for tailored approaches in evaluating and managing hearts from different donation types for transplantation. Transcript Today’s date is August 02, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies. A retrospective analysis utilizing the Cardiogenic Shock Working Group registry provided comparative data on patient trajectories and outcomes in cardiogenic shock. The study specifically compared individuals receiving heart replacement therapies versus those who did not during their index hospitalization. Cardiogenic shock severity was characterized using Society for Cardiovascular Angiography and Interventions stages, machine learning-derived phenotypes, and the Comorbidity Risk Index. This analysis yielded foundational comparative insights into patient courses under different management strategies for severe cardiogenic shock. Article number two. Determining an optimal central cannulation strategy for ambulatory veno-venous extracorporeal life support. To address suboptimal cannulation for durable veno-venous extracorporeal membrane oxygenation support in end-stage chronic obstructive pulmonary disease, four novel central cannulation strategies were designed, fabricated, and evaluated. Current configurations for long-term respiratory support are suboptimal, prompting the development of these new approaches for durable artificial lung therapies. The evaluation provided crucial insights into improved cannulation configurations, offering critical alternatives for chronic obstructive pulmonary disease patients facing donor lung scarcity. This work advances long-term physiological support for patients requiring prolonged respiratory assistance. Article number three. Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device. This study investigated single-beat right ventricular-pulmonary artery coupling using elastance-based indices to identify residual heart failure risk in 70 adults with HeartMate 3 left ventricular assist devices. Patients underwent pre-discharge right heart catheterization after optimized device support. The findings demonstrated how right ventricular-pulmonary artery interaction, measured via specific indices, correlates with the presence of ongoing heart failure despite left ventricular assist device implantation. This work provides new understanding of the mechanisms contributing to residual heart failure in this population. Article number four. The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction. The A. S. S. I. S. T. chronic lung allograft dysfunction study, a multicenter, phase two, double-blind, randomized controlled trial, demonstrated the impact of intravenous allogenic bone marrow-derived mesenchymal stromal cells in lung transplant recipients with new-onset chronic lung allograft dysfunction. This trial, involving participants aged 18 years or older more than six months post-transplant, focused on those with a persistent fall in forced

  8. Aug 1

    Higher E. D. Diuretics Cut Heart Failure Hospitalizations. 08/01/26

    Welcome to Cardiology Today – Recorded August 01, 2026. This episode summarizes 5 key cardiology studies on topics like acute myocardial infarction and cardiogenic shock. Key takeaway: Higher E. D. Diuretics Cut Heart Failure Hospitalizations.. Article Links: Article 1: Relationship Between Ambulatory Pulmonary Artery Pressures and Heart Failure Hospitalizations in Patients With Chronic Heart Failure. (JACC. Heart failure) Article 2: Higher Emergency Department Diuretic Dosing for Acute Heart Failure Associated With Lower Risk of Hospitalization. (JACC. Heart failure) Article 3: Hospital Referral Region Dissimilarity and Black-White Differences in Heart Failure Outcomes Among Medicare Beneficiaries. (JACC. Heart failure) Article 4: Cardiogenic shock in heart transplant recipients: A multicenter cohort study with matched analysis. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Article 5: Beyond the STEMI paradigm: Expanding the scope of microAxial flow pump in cardiogenic shock. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation) Full episode page: https://podcast.explainheart.com/podcast/higher-e-d-diuretics-cut-heart-failure-hospitalizations-08-01-26/ Featured Articles Article 1: Relationship Between Ambulatory Pulmonary Artery Pressures and Heart Failure Hospitalizations in Patients With Chronic Heart Failure. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42535981 Summary: This study demonstrated that baseline systolic, diastolic, and mean pulmonary artery pressures, along with their changes from baseline to six months, were independent predictors of a heart failure hospitalization within two years. The analysis, drawn from CardioMEMS data including the CHAMPION study, identified these ambulatory hemodynamic markers as crucial indicators. These findings establish the prognostic utility of continuous pulmonary artery pressure monitoring in patients with chronic heart failure. This information is vital for identifying individuals at elevated risk of future decompensation. Article 2: Higher Emergency Department Diuretic Dosing for Acute Heart Failure Associated With Lower Risk of Hospitalization. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42535982 Summary: This study found that higher initial diuretic dosing in the emergency department for acute heart failure was associated with a lower risk of hospital admission. The retrospective cohort analysis identified this association as crucial for managing acute decompensation. Results established an important link between early aggressive diuretic therapy and improved patient outcomes. This demonstrates that judicious higher dosing at presentation can significantly impact hospitalization rates. Article 3: Hospital Referral Region Dissimilarity and Black-White Differences in Heart Failure Outcomes Among Medicare Beneficiaries. Journal: JACC. Heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42535980 Summary: This study utilized U. S. Medicare data to identify hospitalizations among Black and White patients with heart failure. The analysis revealed that hospital referral region dissimilarity was associated with significant Black-White differences in heart failure outcomes, including mortality and rehospitalization rates. These findings underscore how geographic segregation of care influences racial disparities in cardiovascular health. The data demonstrated specific patterns of care delivery affecting health equity among Medicare beneficiaries. Article 4: Cardiogenic shock in heart transplant recipients: A multicenter cohort study with matched analysis. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/42001917 Summary: This multicenter study characterized the prognosis of heart transplant recipients experiencing graft failure-related cardiogenic shock, occurring at least one month post-transplantation. Researchers identified key predictors of one-year event-free survival within this specific patient population. The analysis also compared these outcomes to those of patients with other etiologies of cardiogenic shock. This research provides critical insights into the management and risk stratification for this complex and high-risk cohort. Article 5: Beyond the STEMI paradigm: Expanding the scope of microAxial flow pump in cardiogenic shock. Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41966345 Summary: This study compared clinical profiles, management strategies, and outcomes between patients with acute myocardial infarction-related cardiogenic shock and those with non-ischemic cardiogenic shock supported by microaxial flow pumps. The retrospective analysis, encompassing Impella C. P. and five point five devices, established distinct differences in patient characteristics and therapeutic responses based on cardiogenic shock etiology. Results showed that outcomes and management varied significantly between these two groups. This research expands the understanding of microaxial flow pump utility beyond acute myocardial infarction-related cases, informing tailored therapeutic strategies. Transcript Today’s date is August 01, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Relationship Between Ambulatory Pulmonary Artery Pressures and Heart Failure Hospitalizations in Patients With Chronic Heart Failure. This study demonstrated that baseline systolic, diastolic, and mean pulmonary artery pressures, along with their changes from baseline to six months, were independent predictors of a heart failure hospitalization within two years. The analysis, drawn from CardioMEMS data including the CHAMPION study, identified these ambulatory hemodynamic markers as crucial indicators. These findings establish the prognostic utility of continuous pulmonary artery pressure monitoring in patients with chronic heart failure. This information is vital for identifying individuals at elevated risk of future decompensation. Article number two. Higher Emergency Department Diuretic Dosing for Acute Heart Failure Associated With Lower Risk of Hospitalization. This study found that higher initial diuretic dosing in the emergency department for acute heart failure was associated with a lower risk of hospital admission. The retrospective cohort analysis identified this association as crucial for managing acute decompensation. Results established an important link between early aggressive diuretic therapy and improved patient outcomes. This demonstrates that judicious higher dosing at presentation can significantly impact hospitalization rates. Article number three. Hospital Referral Region Dissimilarity and Black-White Differences in Heart Failure Outcomes Among Medicare Beneficiaries. This study utilized U. S. Medicare data to identify hospitalizations among Black and White patients with heart failure. The analysis revealed that hospital referral region dissimilarity was associated with significant Black-White differences in heart failure outcomes, including mortality and rehospitalization rates. These findings underscore how geographic segregation of care influences racial disparities in cardiovascular health. The data demonstrated specific patterns of care delivery affecting health equity among Medicare beneficiaries. Article number four. Cardiogenic shock in heart transplant recipients: A multicenter cohort study with matched analysis. This multicenter study characterized the prognosis of heart transplant recipients experiencing graft failure-related cardiogenic shock, occurring at least one month post-transplantation. Researchers identified key predictors of one-year event-free survival within this specific patient population. The analysis also compared these outcomes to those of patients with other etiologies of cardiogenic shock. This research provides critical insights into the management and risk stratification for this complex and high-risk cohort. Article number five. Beyond the STEMI paradigm: Expanding the scope of microAxial flow pump in cardiogenic shock. This study compared clinical profiles, management strategies, and outcomes between patients with acute myocardial infarction-related cardiogenic shock and those with non-ischemic cardiogenic shock supported by microaxial flow pumps. The retrospective analysis, encompassing Impella C. P. and five point five devices, established distinct differences in patient characteristics and therapeutic responses based on cardiogenic shock etiology. Results showed that outcomes and management varied significantly between these two groups. This research expands the understanding of microaxial flow pump utility beyond acute myocardial infarction-related cases, informing tailored therapeutic strategies. Thank you for listening. Don’t forget to subscribe. Keywords acute myocardial infarction, cardiogenic shock, geographic segregation, heart transplant recipients, ambulatory pulmonary artery pressure, racial disparities, heart failure hospitalization, hospital referral regions, Impella, emergency department, loop diuretic, hospitalization risk, Medicare beneficiaries, heart failure outcomes, chronic heart failure, one-year survival, acute heart failure, intravenous diuretics, hemodynamic monitoring, CardioMEMS, graft failure, microaxial flow pumps, non-ischemic cardiogenic shock, retransplantation. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • Follow The post Higher E. D. Diuretics Cut Heart Failure Hospitalizations. 08/01/

See All (356)

About

Stay current with cardiovascular medicine without the time commitment. Every morning, we deliver concise audio summaries of the latest original research from top cardiology journals. Top 5 breakthrough studies briefed in under 5 minutes (perfect for your commute or between patients). PubMed links included for full articles. Perfect for cardiologists, cardiothoracic surgeons, cardiac nurses, researchers, and healthcare workers who need to stay informed but lack time to scan multiple journals daily. For educational and reference purposes only. Not intended as medical advice.

Information

  • Creator
    Deconstructed Cardiology
  • Years Active
    2025 - 2026
  • Episodes
    356
  • Rating
    Clean
  • Copyright
    © 2025 Deconstructed Cardiology LLC
  • Show Website
    Cardiology Today

You Might Also Like